Venture Briefing Lugano

The Venture Briefing event series is designed to help students, PhD, postdoc, academic staff & alumni interested in pursuing an entrepreneurial career to take their first steps towards building a successful company.

Event schedule:

11:45 - Doors open
12:00 - Presentation of different support programmes by Venturelab
12:15 - Keynote speech by Priyanka Dutta-Passecker, Healiva (startup incubated at USI Startup Centre)
12:30 - Q&A
12:45 - Networking lunch

Support programmes that will be presented during the event:

• Venture Kick (up to CHF 150,000 pre-seed capital for business development)
• InnoBooster (up to CHF 150,000 grant to accelerate market entry)
• First Ventures (up to CHF 150,000 financial support and tailored coaching program for University of Applied Science students)

About the keynote speaker

Priyanka Dutta-Passecker holds a Ph.D. in Neuroscience from Trinity College Dublin and a dual executive MBA from WU Executive Academia and Carlson Business School, Minnesota, with 15+ years of experience in the pharmaceutical and biotechnology industry.
 
Healiva, based in Lugano, is a patient-centric Swiss Biotech company, delivering personalised therapy to improve patient’s quality of life. The company uses a multi-pronged approach to address patient needs by combining cell therapies, enzyme technology and medical devices to deliver tailored solutions for chronic wounds - with the potential to help 156 million patients world-wide, especially those with diabetis. Healiva is the first Biotech to offer multiple end-to-end, intuitive wound care products that can be personalised whilst remaining affordable. Healiva has been a winner of the Venture Leaders Biotech 2022, representing the Swiss National Startup Team in Boston, USA.

For more details and registration click here.